Companies: 10,795·Total market cap: $144.5T
Hemostemix Inc.

Hemostemix Inc.

HMTXFOTCHealthcare● Active
$0.04
+$0.00(+0.00%)
Market Cap$7516265
P/E Ratio
52W High$0.12
52W Low$0.0377
Overview

Hemostemix Inc. (HMTXF) Market Cap & Net Worth

Live market cap, enterprise value, and global rank — multi-year chart and annual table below.

hmtxf · market cap & enterprise value · FMP · as of Jun 5, 2026

Core market cap & key metrics

As of Jun 5, 2026, Hemostemix Inc. (HMTXF) has a market cap — also referred to as its net worth or valuation — of $7,516,265, making it one of the top most valuable companies globally. Market Cap = $0.04 × shares outstanding.

Market Cap (Net Worth)$7,516,265hmtxf market cap 2026
Enterprise ValuemktCap + debt − cash
1-Year Changevs one year ago
Global Rankinglargest company by mkt cap
All-Time High$0hmtxf highest market cap ever
Stock Price$0.04OTC · Jun 5, 2026
How is Market Cap calculated?Market Cap = Stock Price × Shares Outstanding

About Market Cap, Net Worth & Valuation

Hemostemix Inc. (HMTXF) has a market cap — also referred to as its net worth or valuation — of $7,516,265 as of Jun 5, 2026, making it the #0 most valuable company globally. Market Cap = Stock Price × Shares Outstanding.

Hemostemix Inc. reached its all-time high market cap of $0 on —. Comparing the Hemostemix Inc. market cap history illustrates one of the most extraordinary corporate growth stories.

Investors frequently compare Hemostemix Inc. net worth vs peers and ask how Hemostemix Inc. valuation compares to other countries. Its market cap reflects continued investor confidence.

Data: FMP · year-end market cap · not investment advice

Frequently Asked Questions

HMTXF market cap · 6 questions

Hemostemix Inc.'s net worth — measured as market capitalization — is $7,516,265 as of Jun 5, 2026. It ranks #0 globally. Market Cap = $$0.04 (price) × shares outstanding.

HMTXF net worth 2026market cap vs book valuelargest companies by market cap
Data: Financial Modeling Prep · Market cap updates daily · For informational purposes only, not investment advice.